SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

11 Jan 2019 Evaluate

Dr. Reddy’s Laboratories has informed about submission of a Press Release titled ‘Dr. Reddy's to release 03 FY19 results on February 1, 2019, Earnings call slated for February 1, 6:30 PM IST / 8:00 AM EST’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1289.80 -3.45 (-0.27%)
11-May-2026 14:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.75
Dr. Reddys Lab 1289.80
Cipla 1308.60
Zydus Lifesciences 954.90
Lupin 2280.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×